tiprankstipranks
Trending News
More News >
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market

Invex Therapeutics Ltd. (IXC) Income Statement

Compare
2 Followers

Invex Therapeutics Ltd. Income Statement

Last quarter (Q4 2025), Invex Therapeutics Ltd.'s total revenue was AU$229.08K, an increase of 1781.59% from the same quarter last year. In Q4, Invex Therapeutics Ltd.'s net income was AU$-120.33K. See Invex Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 229.08KAU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00
Gross Profit
AU$ 229.08KAU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00
Operating Expenses
AU$ 938.39KAU$ 3.35MAU$ 8.98MAU$ 4.22MAU$ 2.44M
Depreciation and Amortization
AU$ 709.30KAU$ 2.13MAU$ 8.55MAU$ 0.00AU$ 0.00
EBITDA
AU$ 0.00AU$ -720.00KAU$ -8.21MAU$ -4.14MAU$ -2.28M
Operating Income
AU$ -709.30KAU$ -2.13MAU$ -8.55MAU$ -4.03MAU$ -2.44M
Other Income/Expenses
AU$ 232.44KAU$ 491.82KAU$ 797.08KAU$ 79.88KAU$ 158.79K
Pretax Income
AU$ -476.87KAU$ -2.85MAU$ -7.75MAU$ -3.95MAU$ -2.28M
Net Income
AU$ -476.87KAU$ -1.64MAU$ -7.75MAU$ -3.95MAU$ -2.28M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.02AU$ -0.10AU$ -0.05AU$ -0.03
Diluted EPS
AU$ -0.01AU$ -0.02AU$ -0.10AU$ -0.05AU$ -0.03
Weighted Average Shares Outstanding
75.69M 75.31M 75.15M 75.15M 75.15M
Weighted Average Shares Outstanding (Diluted)
75.69M 75.31M 75.15M 75.15M 75.15M
Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History